Fresh Tracks Therapeutics Overview

Fresh Tracks Therapeutics Total Revenue

Revenue analysis for FRTX.

Quarterly Revenue

N/A

As of Dec 2023

Annual Revenue (TTM)

$8.01M

↑ 15.31% YoY

Trailing 12 months ending Dec 2023

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin